The First and Only FDA Approved Anti-CD38 + VRd Therapy in Patients with NDMM Not Eligible for Transplant
This program is not CME accredited.
This event has ended.
Thank you to those who were able to join us.
- November 14, 2024
- 8:00 PM EST - 9:00 PM EST
- 1 Hour
